Connect your AI

Haemonetics HAE Prepaid & Other Current

Prepaid & Other Current at other companies

TFX

TeleflexTFX

$149.81M+5.8%

Boston ScientificBSX

$729M-3.6%

MedtronicMDT

$2.97B+4.0%

LivaNovaLIVN

$38.48M-18.6%

ICU MedicalICUI

$118.25M+56.9%

Merit Medical SystemsMMSI

$29.27M+17.1%

Other financials

Income statement

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

Market cap$3.31B-18.0%

Profitability

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Haemonetics's prepaid & other current?: Haemonetics (HAE) reported prepaid & other current of $66.21M in Q1 2026.
How has Haemonetics's prepaid & other current changed year-over-year?: Haemonetics's prepaid & other current increased by 9.6% year-over-year, from $60.41M to $66.21M.
What is the long-term trend for Haemonetics's prepaid & other current?: Over 5 years (2021 to 2026), Haemonetics's prepaid & other current has grown at a 5.3% compound annual growth rate (CAGR), from $51.07M to $66.21M.
What does prepaid & other current mean?: Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.